Lise Eliot

Lise Eliot, PhD, is currently the Head of Medical Writing in Regulatory Affairs at Arrowhead Pharmaceuticals. They have held prominent roles in medical writing and clinical development, including Senior Director positions at Marker Therapeutics, Inc. and Turning Point Therapeutics, as well as serving as Executive Director at Intercept Pharmaceuticals. Lise also has experience as President of LKAN Clinical and has held various leadership positions in the pharmaceutical industry since 2003. They are pursuing a Doctor of Philosophy in Pharmaceutical Sciences at the University of Alberta.